Back to Search
Start Over
Living on the edge : Substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders
- Source :
- BMC Biology, BMC Biology, 14(1):107. BioMed Central Ltd., BMC Biology, 14. BioMed Central Ltd.
- Publication Year :
- 2016
-
Abstract
- Background Defects in genes involved in mitochondrial fatty-acid oxidation (mFAO) reduce the ability of patients to cope with metabolic challenges. mFAO enzymes accept multiple substrates of different chain length, leading to molecular competition among the substrates. Here, we combined computational modeling with quantitative mouse and patient data to investigate whether substrate competition affects pathway robustness in mFAO disorders. Results First, we used comprehensive biochemical analyses of wild-type mice and mice deficient for medium-chain acyl-CoA dehydrogenase (MCAD) to parameterize a detailed computational model of mFAO. Model simulations predicted that MCAD deficiency would have no effect on the pathway flux at low concentrations of the mFAO substrate palmitoyl-CoA. However, high concentrations of palmitoyl-CoA would induce a decline in flux and an accumulation of intermediate metabolites. We proved computationally that the predicted overload behavior was due to substrate competition in the pathway. Second, to study the clinical relevance of this mechanism, we used patients’ metabolite profiles and generated a humanized version of the computational model. While molecular competition did not affect the plasma metabolite profiles during MCAD deficiency, it was a key factor in explaining the characteristic acylcarnitine profiles of multiple acyl-CoA dehydrogenase deficient patients. The patient-specific computational models allowed us to predict the severity of the disease phenotype, providing a proof of principle for the systems medicine approach. Conclusion We conclude that substrate competition is at the basis of the physiology seen in patients with mFAO disorders, a finding that may explain why these patients run a risk of a life-threatening metabolic catastrophe. Electronic supplementary material The online version of this article (doi:10.1186/s12915-016-0327-5) contains supplementary material, which is available to authorized users.
- Subjects :
- Male
Proteomics
0301 basic medicine
Physiology
Metabolite
NETHERLANDS
Dehydrogenase
Plant Science
Mitochondrion
MCAD DEFICIENCY
Biochemistry
Acyl-CoA Dehydrogenase
Substrate Specificity
Mice
chemistry.chemical_compound
0302 clinical medicine
Multiple acyl-CoA dehydrogenase deficiency
Structural Biology
DEHYDROGENASE-DEFICIENCY
Multiple Acyl-CoA Dehydrogenase Deficiency
PHOSPHORYLATION
Beta oxidation
Mice, Knockout
Ecology
biology
Agricultural and Biological Sciences(all)
Fatty Acids
CHAIN ACYL-COA
Mitochondria
Systems medicine
Medium-chain acyl-CoA dehydrogenase deficiency
BETA-OXIDATION
General Agricultural and Biological Sciences
Oxidation-Reduction
Metabolic Networks and Pathways
Research Article
Biotechnology
ENZYME
Kinetic modeling
Evolution
RAT-LIVER
METABOLISM
Lipid Metabolism, Inborn Errors
General Biochemistry, Genetics and Molecular Biology
03 medical and health sciences
Behavior and Systematics
Carnitine
Journal Article
Animals
Humans
Computer Simulation
Ecology, Evolution, Behavior and Systematics
Biochemistry, Genetics and Molecular Biology(all)
Computational Biology
Acyl CoA dehydrogenase
Robustness (evolution)
COENZYME
Cell Biology
Medium-Chain Acyl-CoA Dehydrogenase Deficiency
Lipid Metabolism
Mice, Inbred C57BL
Mitochondrial fatty-acid oxidation
Disease Models, Animal
030104 developmental biology
chemistry
biology.protein
030217 neurology & neurosurgery
Genetics and Molecular Biology(all)
Developmental Biology
Subjects
Details
- Language :
- English
- ISSN :
- 17417007
- Database :
- OpenAIRE
- Journal :
- BMC Biology, BMC Biology, 14(1):107. BioMed Central Ltd., BMC Biology, 14. BioMed Central Ltd.
- Accession number :
- edsair.doi.dedup.....4b21d66b35c86202977865caec5fa6a4